2 active not recruiting, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Not yet recruiting 1 |
Follow Maintenance Therapy: new trials by email Literature Review of Maintenance Therapy trials Research Report on Maintenance Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML Gilteritinib + Azacitidine + Venetoclax, Cytarabine + Daunorubicin (or Idarubicin) + Gilteritinib, Re-induction Therapy - AML, Adult | Phase 3 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 300 | 2026-04-30 | 2026-03-25 |
| CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL P regimen, Course A1 + Vin, Course B1 +Vin - Pediatric Anaplastic Large Cell Lymphoma | Phase 3 | Active not recruiting | Children's Cancer Group, China | 172 | 2021-03-01 | 2026-03-19 |
| LBL-2016 for Children or Adolescents in China Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, 6-mercaptopurine,Methotrexate, Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Doxorubicin, 6-mercaptopurine - Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | Children's Cancer Group, China | 150 | 2016-01-01 | 2026-03-18 |
Leukemia, Myeloid, Acute (1) · Lymphoma, Large-Cell, Anaplastic (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Children's Cancer Group, China (2) · Institute of Hematology & Blood Diseases Hospital, China (1)
China (2)
Yi-Jin Gao, M.D. (1) · Yijin Gao, MD (1)
PMID 10627444, PMID 16421426, PMID 17003366, PMID 19139435, PMID 19433688, PMID 20679620, PMID 23389497, PMID 24344215, PMID 26887549, PMID 28273702, PMID 28787259, PMID 32661576, PMID 32730187, PMID 32987765, PMID 35478711